Watch this exclusive on-demand webinar featuring Allgenesis Biotherapeutics as they unveil insights from their Phase 2A DME program. Learn how the trial was designed, and why working with Lexitas and Voxeleron facilitated efficient communication with sites and faster decision-making by management.
Access Webinar: How Allgenesis Evaluated Unique Endpoints to Advance its Phase 2A DME Study